Drug Testing for Newborn Exposure to Illicit Substances in Pregnancy: Pitfalls and Pearls
2011

Drug Testing for Newborns Exposed to Illicit Substances in Pregnancy

publication Evidence: moderate

Author Information

Author(s): Karen J. Farst, Jimmie L. Valentine, R. Whit Hall

Primary Institution: University of Arkansas for Medical Sciences

Hypothesis

How can drug testing in newborns help identify those exposed to illicit substances during pregnancy?

Conclusion

Drug testing can help identify newborns exposed to illicit drugs, which is crucial for ensuring their safety and providing necessary support services.

Supporting Evidence

  • 5-10% of women self-report drug use during pregnancy, but testing shows higher rates.
  • Identification of drug exposure can help assess the mother's need for services.
  • Drug testing can be performed on various biological samples like urine and meconium.

Takeaway

This study talks about how testing newborns for drugs can help doctors know if the baby might need extra help because their mom used drugs while pregnant.

Methodology

The paper reviews existing literature and discusses the clinical role of drug testing in newborns.

Potential Biases

There is a risk of bias in testing newborns from poverty or minority backgrounds due to assumptions about substance abuse.

Limitations

The study acknowledges that self-reports of drug use are often inaccurate and that universal drug testing is not practical.

Digital Object Identifier (DOI)

10.1155/2011/951616

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication